PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers Meeting Abstract


Authors: Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; Drilon, A. E.; Arcila, M. E.; Hellmann, M. D.; Li, B. T.
Abstract Title: PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 474s
Language: English
ACCESSION: WOS:000442916003233
DOI: 10.1200/JCO.2018.36.15_suppl.9060
PROVIDER: wos
Notes: Meeting Abstract: 9060 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Eugenia Arcila
    657 Arcila
  2. Mark Kris
    869 Kris
  3. Alexander Edward Drilon
    632 Drilon
  4. Matthew David Hellmann
    411 Hellmann
  5. Bob Tingkan Li
    278 Li
  6. Ai   Ni
    99 Ni
  7. Joshua K Sabari
    36 Sabari
  8. Hira Abbas Rizvi
    122 Rizvi
  9. Wei-Chu Victoria Lai
    59 Lai
  10. Michael David Offin
    170 Offin